<DOC>
	<DOCNO>NCT00936117</DOCNO>
	<brief_summary>The goal clinical research study learn amount posaconazole body different time point give patient leukemia . The safety drug also study . Objectives : Primary : To study plasma pharmacokinetics posaconazole patient newly diagnose acute myelogenous leukemia ( AML ) high-risk myelodysplastic syndrome ( HR-MDS ) undergo induction chemotherapy relapse refractory patient receive salvage chemotherapy . Secondary : To evaluate safety posaconazole give prophylaxis .</brief_summary>
	<brief_title>Pharmacokinetics Posaconazole Prophylaxis Acute Leukemia</brief_title>
	<detailed_description>Chemotherapy low immune system function , cause fungal infection occur easily . The standard treatment prevention infection include drug voriconazole liposomal amphotericin B help prevent fungus grow . The Study Drug : Posaconazole design block ergosterol synthesis ( part fungal membrane ) . This may help prevent fungal infection . Study Drug Administration : If find eligible take part study , take posaconazole mouth 3 time per day . Posaconazole liquid . You take study drug full meal liquid nutritional supplement ( protein shake ) . If able eat food , take carbonate beverage ( soda ) . Food Drug Diary : You also give food drug diary write time take dose . You also record time eaten describe ate drank meal . This information use find number calorie amount protein , carbohydrate , fat consume . You give small bag keep drug diary . You return diary last blood draw . Blood Draws Pharmacokinetics ( PK ) Testing : While study , blood ( 1 teaspoon time ) drawn PK testing . PK test measure amount study drug body different time point . - Days 1 , 3 , 10 , first dose study drug 3 , 5 , 10 hour first dose day - Days 2 4 , 24 hour first dose day Blood ( 1 teaspoon ) also draw PK test 1 time follow time point : - Before start new dose study drug , dose need raise - If stop taking study drug due intolerable side effect fungal infection Note already hospital day PK blood draw , need stay hospital 10 hour day . Length Study : You take study drug 42 day . You take study experience intolerable side effect , develop invasive fungal infection , doctor think best interest . This investigational study . Posaconazole FDA approve commercially available prevention fungal infection . Up 25 patient take part study . All enrol MD Anderson .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Mycoses</mesh_term>
	<mesh_term>Posaconazole</mesh_term>
	<criteria>1 . Patients newly diagnose AML highrisk MDS undergo induction chemotherapy refractory relapse patient AML highrisk MDS receive first second salvage chemotherapy . ( Salvage patient define patient achieve remission relapse patient refractory initial frontline chemotherapy ) 2 . Age &gt; 18 year able take oral intake . 3 . Patients must sign informed consent . 4 . Patients agree medically approve form contraception 5 . Patients prior antifungal prophylaxis voriconazole , itraconazole fluconazole eligible complete 3 day washout period voriconazole , 14 day washout period itraconazole 7 day washout period fluconazole 1 . Patients history anaphylaxis attribute azole compound 2 . Patients clinical evidence indicate proven probable invasive fungal infection prior enrollment ( EORTC criterion ) 3 . Patients baseline total bilirubin level &gt; 3 time upper normal limit ( i.e . &gt; 3.0 mg/dl ) ; baseline SGPT &gt; 5 time upper limit normal . 4 . Patients receive medication contraindicate use posaconazole 5 . Patients baseline creatinine level NCI grade 3 ( &gt; 3.0 6.0 X ULN ) 6 . Patients baseline QTc prolongation NCI grade 1 ( QTc &gt; 0.45 0.47 second ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Cancer Blood</keyword>
	<keyword>Cancer Bone Marrow</keyword>
	<keyword>Acute Leukemia</keyword>
	<keyword>AML</keyword>
	<keyword>Fungal infection</keyword>
	<keyword>Prophylaxis</keyword>
	<keyword>Posaconazole</keyword>
	<keyword>SCH 56592</keyword>
	<keyword>Noxafil</keyword>
	<keyword>Chemotherapy</keyword>
</DOC>